Lisdexamfetamine Dimesylate 72205-0134
Product NDC
72205-0134- Manufacturer
- Novadoz Pharmaceuticals Llc
- Dosage Form
- Tablet, Chewable
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- February 2, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA218306
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lisdexamfetamine Dimesylate | 30 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Packaging Options(1)
100 TABLET, CHEWABLE in 1 BOTTLE (72205-134-91)